Table 3 Unadjusted and adjusted ORs for the association in clinical characteristics between men and women (total population, n = 8914)
Gender differences (reference group is men)
Unadjusted OR* (95% CI)OR* adjusted for age (95% CI)
Current smoker0.28 (0.24 to 0.33)0.36 (0.31 to 0.42)
Heavy alcohol drinker, ever0.10 (0.07 to 0.13)0.12 (0.09 to 0.16)
History of hypertension1.55 (1.42 to 1.69)1.51 (1.39 to 1.65)
Diabetes1.18 (1.09 to 1.30)1.17 (1.06 to 1.29)
Stroke or transient ischaemic attack (TIA)1.15 (1.03 to 1.28)0.98 (0.87 to 1.10)
History of renal dysfunction0.79 (0.71 to 0.87)0.67 (0.60 to 0.75)
Respiratory disease0.92 (0.84 to 1.00)0.84 (0.77 to 0.93)
Cumulative evidence for CAD†0.65 (0.60 to 0.71)0.62 (0.57 to 0.68)
Dilated cardiomyopathy0.40 (0.30 to 0.53)0.57 (0.42 to 0.77)
Atrial fibrillation, ever1.18 (1.09 to 1.29)1.03 (0.95 to 1.13)
Ward of admission:
    Cardiology0.50 (0.46 to 0.54)0.66 (0.61 to 0.73)
    General internal medicine1.85 (1.70 to 2.01)1.47 (1.35 to 1.61)
    Other ward1.30 (1.11 to 1.51)1.01 (0.86 to 1.18)
Assessment of LV function:0.51 (0.47 to 0.56)0.67 (0.61 to 0.74)
    LVSD‡0.33 (0.29 to 0.37)0.35 (0.32 to 0.39)
Echocardiography performed:0.57 (0.52 to 0.62)0.74 (0.67 to 0.81)
    Mitral stenosis3.54 (2.57 to 4.89)3.89 (2.79 to 5.41)
    Aortic stenosis1.66 (1.37 to 2.01)1.39 (1.14 to 1.70)
    Mitral regurgitation1.12 (1.00 to 1.25)1.12 (1.00 to 1.25)
    Aortic regurgitation1.28 (1.05 to 1.55)1.17 (0.96 to 1.42)
  • *OR >1 correlates with a higher prevalence in women.

  • †CAD (coronary artery disease): myocardial infarction, angina, or revascularisation.

  • ‡LVSD =  EF<40% or moderate to severe LV systolic dysfunction.